<DOC>
	<DOC>NCT00673725</DOC>
	<brief_summary>To assess the efficacy of Locobase REPAIR速 when used in children with moderate to severe AD</brief_summary>
	<brief_title>Locobase速 REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Has given written informed consent (parents or guardian, child if applicable) Moderate to severe AD Continuous use of topical corticosteroid or topical calcineurin inhibitor (TCI) as active treatment of AD for more than 4 weeks prior to screening (no change in topical corticosteroid or TCI is allowed between screening and day 1) In the opinion of the investigator, subject is unlikely to require a significant change to his/her current treatment regimen during the study period Has infected lesions The last assessment of any clinical study within 3 months prior to the expected date of entering into the study Current use of Locobase速 REPAIR Known allergy to Locobase速 REPAIR or any of its components Any clinical condition which, in the opinion of the investigator, would not allow safe completion of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>